Century Therapeutics, Inc. (NASDAQ: IPSC) has unveiled its first program targeting Type 1 diabetes, introducing an engineered ...

An early-screening and awareness campaign calling for greater understanding and support for people with Type 1 diabetes was ...

Diabetes is one of the most common metabolic disorders worldwide, but not all types are the same. Type 1 and Type 2 diabetes differ in causes, age of onset, treatment methods, and long-term effects.

This article is part of “Innovations In: Type 1 Diabetes,” an editorially independent special report that was produced with financial support from Vertex. In 2024 Stephen Rich and his colleagues ...